ClinicalTrials.Veeva

Menu

A Study of HD-tDCS and Cognitive Training to Improve Cognitive Function in MCI

Medical College of Wisconsin logo

Medical College of Wisconsin

Status

Completed

Conditions

Memory Disorders
Mild Cognitive Impairment
Memory Loss

Treatments

Device: sham HD-tDCS combined with CT
Device: HD-tDCS combined with CT

Study type

Interventional

Funder types

Other

Identifiers

NCT04246164
PRO00035757

Details and patient eligibility

About

The primary objective of this project is to assess the feasibility of multi-field, extended HD-tDCS (MFE-HD-tDCS) with simultaneous computerized CT as a viable intervention to improve cognitive function in patients with MCI. This double-blinded, randomized pilot clinical trial of repetitive daily HD-tDCS/sham HD-tDCS, administered in combination with CT to subjects with MCI in 3 monthly blocks of 5 daily sessions for a total of 15 sessions will enroll 8 participants.

Enrollment

8 patients

Sex

All

Ages

50 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age ≥50-90 years
  2. Willing and able to undergo all procedures
  3. Retains decisional capacity at initial visit
  4. Meets criteria for MCI, amnestic type (Petersen, 2004).

Exclusion criteria

  1. Significant kidney injury requiring hemodialysis
  2. Automatic Internal Cardiac Defibrillator (AICD) or Pacemaker
  3. Significant congestive heart failure
  4. History of clinically significant ischemic or hemorrhagic stroke, or lacune or infarct considered by radiologist likely to cause or contribute significantly to cognitive symptoms
  5. History of thalamic lacunar stroke
  6. Modified Hachinski Ischemia Score >4 points
  7. History of seizure disorder requiring medication
  8. History of brain surgery (for seizure disorder, aneurysms, or benign/malignant tumor)
  9. History of HIV/AIDS
  10. Severe untreated obstructive sleep apnea
  11. Greater than three servings alcohol daily or illicit drug use
  12. Major neurologic disorders other than dementia (e.g., MS, ALS)
  13. Schizophrenia, bipolar disorder, other serious mental illnesses
  14. Other significant medical conditions at investigators' discretion
  15. Pregnancy
  16. Lack of study partner (Participants are allowed to find a new study partner if the original study partner withdraws)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

8 participants in 2 patient groups

HD-tDCS combined with CT
Active Comparator group
Description:
HD-tDCS combined with CT, administered to participants with amnestic MCI (aMCI) in blocks of 5 daily treatments for a total of 15 sessions. There will be one treatment block/month for a total of 3 months
Treatment:
Device: HD-tDCS combined with CT
sham HD-tDCS combined with CT
Sham Comparator group
Description:
sham HD-tDCS combined with CT, administered to participants with amnestic MCI (aMCI) in blocks of 5 daily treatments for a total of 15 sessions. There will be one treatment block/month for a total of 3 months
Treatment:
Device: sham HD-tDCS combined with CT

Trial documents
2

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems